Can a chatbot make clinical trial consent clearer?

NCT ID NCT07756515

Not yet recruiting Knowledge-focused Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This study tests whether a chatbot called CoCo can help people understand what they're agreeing to when they join a clinical trial. Researchers want to see if using the chatbot is practical and if it improves comprehension and satisfaction compared to standard remote consent methods. The study involves 100 English-speaking adults who are being considered for enrollment in other research studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CoCo Chatbot, a patient-facing chatbot designed to obtain informed consent
What this could lead to: If successful, this could make informed consent clearer and more satisfying for patients, potentially improving how clinical trials communicate with participants.
What could go wrong: This is a small feasibility study, so results may not apply broadly. The chatbot may not improve comprehension or satisfaction, and there could be technical or usability issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFORMED CONSENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFORMED CONSENT

Contacts and locations

Locations

UT MD Anderson

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.